{
    "code": "01036400",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01036400",
    "time": "2022-09-23 03:22:37",
    "許可證字號": "衛署藥製字第036400號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "107\/05\/22",
    "發證日期": "82\/05\/22",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00103640001",
    "中文品名": "達芬錠10公絲（塔莫西芬）",
    "英文品名": "TAFEN TABLETS 10MG (TAMOXIFEN)",
    "適應症": "乳癌。",
    "劑型": "110錠劑",
    "包裝": "4-1000錠Alu-Alu鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "TAMOXIFEN (CITRATE)",
    "限制項目": "01國　產 1G不得製造 1R不得製造",
    "申請商名稱": "1406801200  臺灣東洋藥品工業股份有限公司",
    "申請商地址": "台北市南港區園區街3之1號3樓",
    "主製造廠": [
        {
            "製造廠名稱": "1406804300  臺灣東洋藥品工業股份有限公司中壢廠",
            "製造廠廠址": "桃園市中壢區中華路一段８３８號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1010009410",
            "成分名稱": "TAMOXIFEN (CITRATE)",
            "含量描述": "(15.2)",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "010364000001.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01036400&Seq=001&Type=9"
        },
        {
            "title": "010364000001.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01036400&Seq=001&Type=8"
        }
    ]
}